Astrana Health (ASTH) Cash from Financing Activities (2011 - 2026)

Astrana Health has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$16.0 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$16.0 million, up 63.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $597.6 million (up 3986.54% YoY), and the FY2025 annual result was $569.3 million, up 321.28% from the prior year.
• Cash from Financing Activities came in at -$16.0 million for Q1 2026 at Astrana Health, up from -$26.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $648.5 million in Q3 2025 to a low of -$44.2 million in Q1 2025.
• The 5-year median for Cash from Financing Activities is -$3.2 million (2024), against an average of $39.5 million.
• Across the five-year window, Cash from Financing Activities tumbled 1434.4% in 2023 and surged 20428.87% in 2025, its largest moves.
• Astrana Health's Cash from Financing Activities stood at $5.9 million in 2022, then soared by 104.28% to $12.0 million in 2023, then slumped by 227.3% to -$15.3 million in 2024, then plunged by 72.51% to -$26.3 million in 2025, then surged by 39.4% to -$16.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$16.0 million (Q1 2026), -$26.3 million (Q4 2025), and $648.5 million (Q3 2025), per Business Quant data.